ACCESS Newswire

Angara Inc.

25.5.2023 15:05:28 CEST | ACCESS Newswire | Press release

Share
Angara Launches Bespoke Ring Designing Experience 'Create With Angara'

The international online jeweller's latest initiative allows customers to design coloured gemstone engagement and cocktail rings in just a few easy steps.

LONDON, UK / ACCESSWIRE / May 25, 2023 / Leading international fine jeweller Angara announces the debut of Create With Angara, a medium through which customers can turn their dream ring designs into reality and tell their story through the brilliance of coloured gemstones.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Create with Angara
Design your own ring at Angara

The process of designing a ring begins with the centre stone. Customers can choose from the jeweller's extensive library of precious and semi-precious gemstones, hand-selected by GIA-certified gemologists. They can also view the actual stones in 360° before picking the one they'd like on their ring.

Following this, customers can choose every aspect of their ring design till their dream piece eventually comes to life. This includes the head and mount type, the finishing, side stones and metal. To make it even more special, customers can add a signature stone or an engraving to their ring.

Right from the time of its inception, Angara has provided customisation options for jewellery. But Create With Angara is a more exclusive experience with greater collaboration between the customer and Angara's master artisans, who work hand-in-hand to create masterpieces.

To sum it up, Create With Angara is a journey that inspires customers to design jewellery that becomes an extension of who they are. From heartfelt engagement rings in classic as well as contemporary styles to statement cocktail rings that speak volumes of one's individuality, the possibilities are endless.

For more information about Angara, Create With Angara and all the upcoming announcements, please visit https://www.angara.com/uk-en and follow @angarajewelleryuk on social media.

About Angara

Founded in 2005 by husband-wife duo Ankur and Aditi Daga, Angara is an online DTC fine jeweller offering stunning designs dressed with coloured gemstones, diamonds and pearls. All Angara pieces are handcrafted and made to order. A vertically integrated company, with deep familial roots spanning hundreds of years in the gemstone business, Angara handles each step of the process in-house, from stone-cutting, designing, manufacturing, quality control and fulfilment. Angara is headquartered in Los Angeles, California, with additional offices in India, Thailand, Ireland, Australia and Canada. The brand also currently holds licensing deals with Harvard University and Natori. For more information, visit https://www.angara.com/uk-en and follow @angarajewelleryuk on social media.

Contact Information

Angara Inc.
customer.service@angara.com
(844) 527-4367

SOURCE: Angara Inc.

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/757288/Angara-Launches-Bespoke-Ring-Designing-Experience-Create-With-Angara

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release

Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica

Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release

OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release

CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in

CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release

TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye